Doxorubicin-Induced Platelet Activation and Clearance Relieved by Salvianolic Acid Compound: Novel Mechanism and Potential Therapy for Chemotherapy-Associated Thrombosis and Thrombocytopenia

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2022 Dec 23

PMID 36558895

Authors

Wenjing Ma

Zackary Rousseau

Sladjana Slavkovic

Chuanbin Shen

George M Yousef

Heyu Ni

Affiliations

Soon will be listed here.

Abstract

Doxorubicin (Dox) is a widely utilized chemotherapeutic; however, it carries side effects, including drug-induced immune thrombocytopenia (DITP) and increased risk of venous thromboembolism (VTE). Currently, the mechanisms for Dox-associated DITP and VTE are poorly understood, and an effective inhibitor to relieve these complications remains to be developed. In this study, we found that Dox significantly induced platelet activation and enhanced platelet phagocytosis by macrophages and accelerated platelet clearance. Importantly, we determined that salvianolic acid C (SAC), a water-soluble compound derived from Danshen root traditionally used to treat cardiovascular diseases, inhibited Dox-induced platelet activation more effectively than current standard-of-care anti-platelet drugs aspirin and ticagrelor. Mechanism studies with tyrosine kinase inhibitors indicate contributions of phospholipase C, spleen tyrosine kinase, and protein kinase C signaling pathways in Dox-induced platelet activation. We further demonstrated that Dox enhanced platelet-cancer cell interaction, which was ameliorated by SAC. Taken together, these findings suggest SAC may be a promising therapy to reduce the risk of Dox-induced DITP, VTE, and the repercussions of amplified platelet-cancer interaction in the tumor microenvironment.

Citing Articles

Potential Player of Platelet in the Pathogenesis of Cardiotoxicity: Molecular Insight and Future Perspective.

Amin A, Mohajerian A, Ghalehnoo S, Mohamadinia M, Ahadi S, Sohbatzadeh T Cardiovasc Toxicol. 2024; 24(12):1381-1394.

PMID: 39397196 DOI: 10.1007/s12012-024-09924-8.

Recent Advances in the Mechanisms of Cell Death and Dysfunction in Doxorubicin Cardiotoxicity.

Wang T, Ma Y, Gao S, Zhang W, Han D, Cao F Rev Cardiovasc Med. 2024; 24(11):336.

PMID: 39076437 PMC: 11272847. DOI: 10.31083/j.rcm2411336.

Salvianolic acid B inhibits thrombosis and directly blocks the thrombin catalytic site.

Neves M, Ni T, Mackeigan D, Shoara A, Lei X, Slavkovic S Res Pract Thromb Haemost. 2024; 8(4):102443.

PMID: 38993621 PMC: 11238050. DOI: 10.1016/j.rpth.2024.102443.

Potential chemoprotective effects of active ingredients in on doxorubicin-induced cardiotoxicity: a systematic review of and studies.

Wang Q, Li J, Chu X, Jiang X, Zhang C, Liu F Front Cardiovasc Med. 2023; 10:1267525.

PMID: 37915739 PMC: 10616797. DOI: 10.3389/fcvm.2023.1267525.

References

Xu X, Wang Y, Adili R, Ju L, Spring C, Jin J . Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis. Nat Commun. 2018; 9(1):3608. PMC: 6127106. DOI: 10.1038/s41467-018-05806-0. View

Fulop Z, Gref R, Loftsson T . A permeation method for detection of self-aggregation of doxorubicin in aqueous environment. Int J Pharm. 2013; 454(1):559-61. DOI: 10.1016/j.ijpharm.2013.06.058. View

Norris P, Kaur G, Khan R, Zhu G, Ni H, Lazarus A . Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcγ receptor inhibition. Blood. 2021; 137(15):2114-2124. DOI: 10.1182/blood.2020009497. View

Li J, van der Wal D, Zhu G, Xu M, Yougbare I, Ma L . Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Commun. 2015; 6:7737. PMC: 4518313. DOI: 10.1038/ncomms8737. View

Wang Y, Reheman A, Spring C, Kalantari J, Marshall A, Wolberg A . Plasma fibronectin supports hemostasis and regulates thrombosis. J Clin Invest. 2014; 124(10):4281-93. PMC: 4191008. DOI: 10.1172/JCI74630. View

Yang H, Reheman A, Chen P, Zhu G, Hynes R, Freedman J . Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo. J Thromb Haemost. 2006; 4(10):2230-7. DOI: 10.1111/j.1538-7836.2006.02116.x. View

Xu X, Zhang D, Oswald B, Carrim N, Wang X, Hou Y . Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Crit Rev Clin Lab Sci. 2016; 53(6):409-30. DOI: 10.1080/10408363.2016.1200008. View

Meikle C, Kelly C, Garg P, Wuescher L, Ali R, Worth R . Cancer and Thrombosis: The Platelet Perspective. Front Cell Dev Biol. 2017; 4:147. PMC: 5214375. DOI: 10.3389/fcell.2016.00147. View

Feinstein M, Pumiglia K, Lau L . Tyrosine phosphorylation in platelets: its regulation and possible roles in platelet functions. Adv Exp Med Biol. 1993; 344:129-48. DOI: 10.1007/978-1-4615-2994-1_10. View

10.

Perez-Arnaiz C, Busto N, Leal J, Garcia B . New insights into the mechanism of the DNA/doxorubicin interaction. J Phys Chem B. 2014; 118(5):1288-95. DOI: 10.1021/jp411429g. View

11.

Wang Z, Wang J, Xie R, Liu R, Lu Y . Mitochondria-derived reactive oxygen species play an important role in Doxorubicin-induced platelet apoptosis. Int J Mol Sci. 2015; 16(5):11087-100. PMC: 4463691. DOI: 10.3390/ijms160511087. View

12.

McNeil J, Wolfe R, Woods R, Tonkin A, Donnan G, Nelson M . Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. N Engl J Med. 2018; 379(16):1509-1518. PMC: 6289056. DOI: 10.1056/NEJMoa1805819. View

13.

Badlou B, Wu Y, Smid W, Akkerman J . Platelet binding and phagocytosis by macrophages. Transfusion. 2006; 46(8):1432-43. DOI: 10.1111/j.1537-2995.2006.00913.x. View

14.

Huang Z, Zeng C, Zhu L, Jiang L, Li N, Hu H . Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase. J Thromb Haemost. 2010; 8(6):1383-93. DOI: 10.1111/j.1538-7836.2010.03859.x. View

15.

Shen C, Liu M, MacKeigan D, Chen Z, Chen P, Karakas D . Viper venoms drive the macrophages and hepatocytes to sequester and clear platelets: novel mechanism and therapeutic strategy for venom-induced thrombocytopenia. Arch Toxicol. 2021; 95(11):3589-3599. DOI: 10.1007/s00204-021-03154-5. View

16.

Song J, Zhang W, Zhang W, Feng Z, Xie T, Du G . [Pharmacokinetics of salvianolic acid A after single intravenous administration in Rhesus monkey]. Yao Xue Xue Bao. 2016; 50(9):1142-7. View

17.

Ni H, Freedman J . Platelets in hemostasis and thrombosis: role of integrins and their ligands. Transfus Apher Sci. 2003; 28(3):257-64. DOI: 10.1016/S1473-0502(03)00044-2. View

18.

Gay L, Felding-Habermann B . Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011; 11(2):123-34. PMC: 6894505. DOI: 10.1038/nrc3004. View

19.

Menozzi M, Valentini L, Vannini E, ARCAMONE F . Self-association of doxorubicin and related compounds in aqueous solution. J Pharm Sci. 1984; 73(6):766-70. DOI: 10.1002/jps.2600730615. View

20.

Zhang C, Pan Y, Cai R, Guo S, Zhang X, Xue Y . Salvianolic acid A increases the accumulation of doxorubicin in brain tumors through Caveolae endocytosis. Neuropharmacology. 2020; 167:107980. DOI: 10.1016/j.neuropharm.2020.107980. View